About Navion Neurosciences
Navion Neurosciences is a private company based in Charlottesville, Virginia. It has reported $10,904,972 raised in three offerings on Form D since May 2023. Its chief executive is Andrew Krouse.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Sep 22, 2026 | $1,949,980of $5.0M target | 6 | $324K | EquityRule 506(b) | Form D ↗ |
| Jul 17, 2024 | Jul 31, 2024amended Sep 10, 2024 | $3,999,986of $4.4M target | 6 | $666K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 17, 2023 | May 31, 2023 | $4,955,006of $5.3M target | 8 | $619K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $10,904,972 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Navion Neurosciences's Form D filed Sep 22, 2026.
Andrew Krouse
Founder, President & Chief Executive Officer, director
Also a chief executive officer and director at Slate Bio.
MB
Marianne Bjordal
Director
SR
Earlier filings also listed Gerry Brunk (director, last listed Sep 2024) and Kurt Woerpel (executive officer, last listed May 2023).